Skip to content

OCON Therapeutics vs Ro5

OCON Therapeutics logo

OCON Therapeutics

We revolutionize women's quality of life and freedom of choice with healthier, safer uterine drug-delivery solutions

30 employees · est. 2020 · Israel

VS
Ro5 logo

Ro5

Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph

12 employees · est. 2018 · London, United Kingdom

Ro5 is the older company (2020 vs 2018).

Side-by-Side Comparison

OCON Therapeutics Ro5
Founded
2020 2018 older
Headquarters
Israel London, United Kingdom
Employees
30 12
Industry
Health Care, Pharmaceutical AI, Biotechnology, Health Care
Funding Stage
Series A Seed
Total Funding
$29.50M Not tracked yet
Funding Rounds
7 3
Services
Development of intrauterine devices, Advanced drug delivery technologies, Non-hormonal contraceptive solutions, Treatment for abnormal uterine bleeding, Innovative therapeutic delivery for endometriosis and myomas Development of innovative medicines targeting core aging mechanisms, Clinical-stage drug trials, AI-enabled R&D for drug discovery and development, Adaptive clinical trial design
Target Customers
Women seeking contraceptive solutions, Women experiencing heavy menstrual bleeding, Healthcare providers in women’s health, Institutions focused on innovation in femtech Investors seeking high returns in biopharma, Healthcare providers focusing on longevity and preventive care, Institutions looking for innovative aging treatments, Pharmaceutical companies interested in strategic collaborations
Taxonomy
Women's HealthInnovative ContraceptionNon-hormonal ContraceptionIntrauterine Drug DeliveryUterine Health SolutionsIUB™ Technology +9 AI In Drug DiscoveryDe Novo Drug DiscoveryADMET AnalysisKnowledge GraphsDigital Transformation In PharmaR&D Software Solutions +9
Website
oconmed.com Ro5.ai
OCON Therapeutics logo

About OCON Therapeutics

OCON Therapeutics is spearheading advancements in women's healthcare with its innovative, non-invasive intra-uterine drug delivery solutions. Founded in 2020, the company operates out of Israel and focuses on enhancing the quality of life and reproductive autonomy for women worldwide. Central to it...

Ro5 logo

About Ro5

Ro5, founded in 2018 and headquartered in the United Kingdom, is making significant strides in the intersection of AI, Biotechnology, and Pharmaceutical industries. With its compelling slogan, "Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.", Ro5 positions itself as a pioneering force...

Also comparing in this category

Comparing more than these two?

Get OCON Therapeutics, Ro5 and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does OCON Therapeutics compare?

A PDF of OCON Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

OCON Therapeutics was founded in 2020, based in Israel, with 30 employees. OCON Therapeutics is spearheading advancements in women's healthcare with its innovative, non-invasive intra-uterine drug delivery solutions. Founded in 2020, the company operates out of Israel and fo. Ro5 was founded in 2018, based in London, United Kingdom, with 12 employees. Ro5, founded in 2018 and headquartered in the United Kingdom, is making significant strides in the intersection of AI, Biotechnology, and Pharmaceutical industries. With its compelling slogan, "Bioact.
OCON Therapeutics has raised $29.50M and Ro5 no disclosed funding. Latest stage: OCON Therapeutics Series A, Ro5 Seed.
Both work in Health Care and Pharmaceutical.

Compare OCON Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at OCON Therapeutics on 5 Mar 2026, and Ro5 on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout